Growth Capital For Life Sciences & Healthcare

Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.

We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.

Our Strategy

Latest News & Announcements

Cell Microsystems Completes $10M Growth Financing

November 15th, 2021|

Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced the closing of a $10 million financing from Telegraph Hill Partners (“THP”), a life science ventur [...]

Specific Diagnostics Announces the First Purchase Orders in Europe

October 4th, 2021|

October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced it has signed multi-year reagent rental agreements with two clinical microbiology laboratories in France, marking the commercialization of Specific’s transformative Reveal rapid AST instrument. T [...]

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

September 14th, 2021|

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced t [...]

View all news